AHA Coding Clinic® for HCPCS - 2007 Quarter 4
ASK the EDITOR
A patient with hepatocellular carcinoma presents for chemoembolization. Through a microcatheter, a chemoembolic mixture of 50 milligrams of Adriamycin (Doxorubicin Hydrochloride) and 10 milliliters of Ethiodol (ethiodized oil) is infused manually into the right hepatic artery. Would it be appropriate to report both the chemotherapy and the embolization for the procedure performed? ...
Subscribe or sign in to view the full article.
Article Overview
This Ask the Editor article explains a coding question involving hepatic artery chemoembolization for hepatocellular carcinoma. It is aimed at coding professionals who need to understand how procedural and drug-administration components are treated in a documented interventional oncology case. The article focuses on the general reporting approach, relevant CPT and HCPCS terminology, and the relationship between the embolization service and the chemotherapy infusion component.
Why This Topic Matters
Interventional oncology cases often involve multiple services in a single encounter, and accurate reporting depends on understanding which parts are considered separate and which are integral to the primary procedure. This article helps readers navigate that distinction in a liver-directed chemoembolization context.
What You Will Learn
- How a hepatic artery chemoembolization case is approached from a coding perspective
- How procedural and drug-administration components are discussed in interventional oncology reporting
- How CPT and HCPCS coding concepts apply to a documented embolization scenario
- How an Ask the Editor format addresses a focused coding question
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Interventional radiology coding specialists
- Oncology coding professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com